← Back to Influence Map
Entity DossierOrganization
PTC THERAPEUTICS, INC.
NJ · US
pharmaceuticals
Tracked direct giving
$0
LDA reported lobbying spend
$1,560,000
Connections
5
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
HCRHealth Issues
$3.5MMMMMedicare/Medicaid
$3.1MTAXTaxation/Internal Revenue Code
$3.1MMEDMedical/Disease Research
$3.0MBUDBudget/Appropriations
$610KTRDTrade
$560KLobbying Firms Retained
In-house lobbyists (filed as its own registrant)$3.0M
LMH STRATEGIC SOLUTIONS$230K
THORN RUN PARTNERS$150K
THE MCMANUS GROUP$120K
TAYLOR STRATEGIES$80K
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Retained | TAYLOR STRATEGIES | Hired TAYLOR STRATEGIES to lobby on Pharmaceuticals | Source |
| Commented on | Centers for Medicare & Medicaid Services | Public comment on CMS-2023-0110: Medicare Program: End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney I | Source |
| Retained | LMH STRATEGIC SOLUTIONS | Hired LMH STRATEGIC SOLUTIONS to lobby (2nd Quarter (Apr 1 - June 30) 2025) | Source |
| Retained | THORN RUN PARTNERS | Hired THORN RUN PARTNERS to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | THE MCMANUS GROUP | Hired THE MCMANUS GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |